Correction of Stress Hyperglycemia in Patients with Acute Surgical Abdominal Diseases
https://doi.org/10.15360/1813-9779-2013-2-29
Abstract
Critically ill patients admitted to intensive care units for the clinical manifestations of stress hyperglycemia represent a group in which attempts are most frequently undertaken to employ various methods of its correction. Objective: to compare different techniques for correction of stress hyperglycemia in patients with acute surgical abdominal disease complicated by peritonitis. Materials and methods: In this single-center randomized controlled trial, stress hyperglycemia was corrected by different procedures in 60 patients with acute surgical abdominal disease complicated by peritonitis. Results: As compared with traditional procedures for correction of stress hyperglycemia, the human insulin analogue aspart (Novorapid) improves stressful glycemic control and reduces the risk of hypoglycemia. During intensive insulin therapy, the ultrashort-acting insulin group showed showed a trend for a reduction in the number of manifestations of multiple organ failure and signs of systemic inflammation and decline in the number of hospital days. The least duration of mechanical ventilation was noted in the small-volume food group.
References
1. Обухова О.А., Кашия Ш.Р., Курмуков ИА., Салтанов А.И.Вестн. интенс. терапии.
2. Данилов И.А., Овечкин А.М.Полиорганная недостаточность: состояние проблемы и современные методы лечения с использованием низкопоточных мембранных технологий.Общая реаниматология.
3. ; 7 (6): 66—71.
4. Селиванов А.В., Яковлев В.Н., Мороз В.В., Марченков Ю.В., Алексеев В.Г.
5. Изменения гормонально-метаболических показателей у пациентов, находящихся в критическом состоянии.Общая реаниматология.2012; 8 (5): 70—76.
6. Михельсон В.А.Специализированное клиническое питание — дополнительные возможности нормализации углеводного обмена в хирургии и интенсивной терапии.Вестн. интенс. терапии.2005; 3: 68—7
7. Руднов В.А.Клиническая значимость и возможные пути коррекции гипергликемии при критических состояниях.Consilium Medicum.2006; 8 (7): 54—61.
8. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R.Intensive insulin therapy in critically ill patients.N. Engl. J. Med.2001; 345 (19): 1359—1367.
9. McCowen K.C., Malhotra A., Bistrian B.R.Stress-induced hypergly-caemia.Crit. Care Clin.2001; 17 (1): 107—124.
10. Thorell A., NygrenJ., Ljungqvist O.Insulin resistance: a marker of surgical stress.Curr. Opin. Clin. Nutr. Metab. Care.1999; 2 (1): 69—7
11. Van den Berghe G., Wouters P., Weekers F., Mohan S., Baxter R.C., Veldhuis J.D., Bowers C.Y., Bouillon R.Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness.J. Clin. Endocrinol. Metab.1999; 84 (4): 1311—1323.
12. Woolfson M.J.Control of bllod glucose during nutritional support in ill patients.Intensive Care Med.2000; 7 (1): 11—14.
Review
For citations:
Nikolenko A.V., Prelous I.N., Leiderman I.N. Correction of Stress Hyperglycemia in Patients with Acute Surgical Abdominal Diseases. General Reanimatology. 2013;9(2):29. (In Russ.) https://doi.org/10.15360/1813-9779-2013-2-29
Views:
1605
Email this article 